Print

New ANDA Cases

Case Name Date Filed Judge Drug Patent No(s).
Pfizer Inc. v. Sun Pharm. Indus. Ltd., 18-1529 (D. Del.) Oct. 3, 2018 Hon. Leonard P. Stark Xeljanz XR® (tofacitinib extended-release tablets) 9,937,181
Spectrum Pharms., Inc. v. Fresenius Kabi USA, LLC, 18-1533 (D. Del.) Oct. 3, 2018 Hon. Colm F. Connolly Beleodaq® (belinostat for injection) 6888027
8835501
Bayer Healthcare LLC v. Apotex Inc., 18-1539 (D. Del.) Oct. 4, 2018 Hon. Leonard P. Stark Nexavar® (sorafenib tosylate tablets) 8877933
9737488
Pharmacyclics LLC v. Sun Pharma Global FZE, 18-1543 (D. Del.) Oct. 5, 2018 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 10,004,746
Patheon Softgels Inc. v. PuraCap Pharm. LLC, 18-14693 (D.N.J.) Oct. 5, 2018 Hon. Michael A. Shipp Naproxen Sodium (EQ 200 mg Base) OTC capsules 9,693,978
9,693,979
10,022,344
10,028,925
Celgene Corp. v. Breckenridge Pharm., Inc., 18-14715 (D.N.J.) Oct. 5, 2018 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
Sun Pharma Global FZE v. Teva Pharm. Indus. Ltd., 18-1552 (D. Del.) Oct. 9, 2018 Hon. Richard G. Andrews Yonsa® (abiraterone acetate tablets) 9,889,144
Sumitomo Dainippon Pharma Co., Ltd. v. Alkem Labs. Ltd., 18-14787 (D.N.J.) Oct. 9, 2018 Hon. Stanley R. Chesler Latuda® (lurasidone HCl tablets)) 9815827
9907794
AstraZeneca AB v. Mylan Pharms. Inc., 18-1562 (D. Del.) Oct. 11, 2018 Hon. Colm F. Connolly Symbicort® (budesonide / formoterol fumarate dehydrate inhalation aerosol) 7,759,328
8,143,239
8,575,137
7,967,011
Shionogi Inc. v. Amneal Pharms. LLC, 18-1564 (D. Del.) Oct. 11, 2018 Hon. Mitchell S. Goldberg Fortamet® (metformin HCl extended-release tablets) 6790459
6866866
Par Pharm., Inc. v. Sandoz Inc., 18-14895 (D.N.J.) Oct. 11, 2018 Hon. Brian R. Martinotti Vasostrict® (vasopressin injection) 9,375,478
9,687,526
9,744,209
9,744,239
9,750,785
9,937,223
AstraZeneca AB v. Mylan Pharms. Inc., 18-0193 (N.D.W.V.) Oct. 12, 2018 Hon. Irene M. Keeley Symbicort® (budesonide / formoterol fumarate dehydrate inhalation aerosol) 7,759,328
8,143,239
8,575,137
7,967,011
Teva Pharms. Int’l GMBH v. Fresenius Kabi USA, LLC, 18-1586 (D. Del.) Oct. 15, 2018 Hon. Colm F. Connolly Bendeka® (bendamustine HCl for injection) 10010533
10052385
Galderma Labs., L.P. v. Sun Pharm. Indus. Ltd., 18-1588 (D. Del.) Oct. 15, 2018 Hon. Leonard P. Stark Oracea® (doxycycline capsules) 10,058,564
Anacor Pharms., Inc. v. Lupin Ltd., 18-1606 Oct. 17, 2018 Hon. Leonard P. Stark Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Valeant Pharms. North America LLC v. Taro Pharms. U.S.A., Inc., 18-15060 (D.N.J.) Oct. 17, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 7,214,506
8,039,494
8,486,978
9,302,009
9,566,272
9,662,394
9,861,698
9,877,955
Millennium Pharms., Inc. v. Hetero Labs Ltd., 18-1639 (D. Del.) Oct. 22, 2018 Hon. Colm F. Connolly Velcade® (bortezomib for injection) 6713446
6958319
Mylan Specialty L.P. v. Aurobindo Pharma USA Inc., 18-15190 (D.N.J.) Oct. 22, 2018 Hon. Freda L. Wolfson AccuNeb® (albuterol sulfate inhaler) 6,702,997
Apotex Inc. v. Gilead Sciences, Inc., 18-6475 (N.D. Cal.) Oct. 23, 2018 Hon. Joseph C. Spero Lexiscan® (regadenoson for injection) 8106183
9085601
Anacor Pharms., Inc. v. Ascent Pharms., Inc., 18-1673 (D. Del.) Oct. 25, 2018 Hon. Richard G. Andrews Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Helsinn Healthcare S.A. v. Baxter Healthcare Corp., 18-1674 (D. Del.) Oct. 25, 2018 Hon. Richard G. Andrews Aloxi® (palonosetron HCl for injection) 8598219
8729094
Astellas US LLC v. Apotex Inc., 18-1675 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Astellas US LLC v. Sandoz Inc., 18-1676 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Astellas US LLC v. Sun Pharma Global FZE, 18-1677 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Astellas US LLC v. Wockhardt Bio AG, 18-1678 (D. Del.) Oct. 25, 2018 Hon. Colm F. Connolly Lexiscan® (regadenoson for injection) 8106183
9085601
Adapt Pharma Operations Ltd. v. Perrigo UK Finco Ltd. Partnership, 18-15287 (D.N.J.) Oct. 25, 2018 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 9,211,253
9,468,747
9,561,177
9,629,965
9,775,838
AstraZeneca AB v. Teva Pharms. USA, Inc., 18-1685 (D. Del.) Oct. 26, 2018 Hon. Colm F. Connolly Symbicort® (budesonide / formoterol fumarate dehydrate inhalation aerosol) 7,759,328
8,143,239
8,575,137
7,967,011
Boehringer Ingelheim Pharms. Inc. v. Mankind Pharma Ltd., 18-1689 (D. Del.) Oct. 26, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. Lupin Ltd., 18-1690 (D. Del.) Oct. 26, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 8551957
9949998
Anacor Pharms., Inc. v. Mylan Pharms. Inc., 18-1699 (D. Del.) Oct. 29, 2018 Hon. Richard G. Andrews Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Mylan Pharms. Inc. v. Sanofi-Aventis Deutschland Gmbh, IPR2019-00122 (PTAB) Oct. 29, 2018 N/A Lantus® SoloStar® (insulin glargine recombinant for injection)
Apidra® SoloStar® (insulin glulisine recombinant for injection)
Toujeo® (Insulin glargine recombinant subcutaneous solution)
Soliqua® (insulin glargine / lixisenatide subcutaneous solution)
Admelog® Solostar® (insulin lispro for injection)
8,992,486
Sucampo AG v. Sun Pharm. Indus., Ltd., 18-15482 (D.N.J.) Oct. 30, 2018 Hon. Freda L. Wolfson Amitiza® (lubiprostone capsules) 7,795,312
8,097,653
8,389,542
8,026,393
8,338,639
8,779,187
8,748,481
Anacor Pharms., Inc. v. Mylan Pharms. Inc., 18-0202 (N.D.W.V.) Oct. 30, 2018 Hon. Irene M. Keeley Kerydin® (tavaborole topical solution) 9,459,938
9,566,289
9,566,290
9,572,823
Neptune Generics, LLC v. Aventis Pharma S.A., IPR2019-00136 (PTAB) Oct. 31, 2018 N/A Jevtana® Kit (cabazitaxel for injection) 5,847,170
Boehringer Ingelheim Pharms. Inc. v. Alkem Labs. Ltd., 18-1738 (D. Del.) Nov. 2, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
8,551,957
9,949,998
7,713,938
Gilead Sciences, Inc. v. Laurus Labs Ltd., 18-1748 (D. Del.) Nov. 6, 2018 Hon. Richard G. Andrews Truvada® (emtricitabine / tenofovir disoproxil fumarate tablets) 6,642,245
6,703,396
8,592,397
8,716,264
9,457,036
9,744,181
Amneal Pharms. LLC v. Almirall, LLC, IPR2019-00207 (PTAB) Nov. 6, 2018 N/A Aczone® (dapsone topical gel) 9,517,219
Boehringer Ingelheim Pharms. Inc. v. Aurobindo Pharma Ltd., 18-1757 (D. Del.) Nov. 7, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® (empagliflozin / metformin tablets)
Synjardy® XR (empagliflozin / metformin extended-release tablets)
8,551,957
9,949,998
7,713,938
Boehringer Ingelheim Pharms. Inc. v. Laurus Labs Ltd., 18-1758 (D. Del.) Nov. 7, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 7579449
9949998
Boehringer Ingelheim Pharms. Inc. v. Alembic Pharms. Ltd., 18-1762 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® (empagliflozin / metformin tablets)
9949998
7713938
Boehringer Ingelheim Pharms. Inc. v. Zydus Pharms. (USA) Inc., 18-1763 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Synjardy® (empagliflozin / metformin tablets)
7,579,449
9,949,998
7,713,938
Boehringer Ingelheim Pharms. Inc. v. Macleods Pharms. Ltd., 18-1764 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® (empagliflozin / metformin tablets)
8,551,957
9,949,998
7,713,938
Boehringer Ingelheim Pharms. Inc. v. Sun Pharm. Indus. Ltd., 18-1765 (D. Del.) Nov. 8, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
8551957
9949998
Insys Therapeutics, Inc. v. Teva Pharms. USA, Inc. 18-1775 (D. Del.) Nov. 9, 2018 Hon. Colm F. Connolly Subsys® (fentanyl sublingual spray) 10,016,403
Kythera Biopharmaceuticals, Inc. v. Slayback Pharma LLC, 18-16012 (D.N.J.) Nov. 9, 2018 Hon. Brian R. Martinotti Kybella® (deoxycholic acid injection) 8,101,593
8,367,649
8,653,058
Celgene Corp. v. Mylan Pharms. Inc., 18-16035 (D.N.J.) Nov. 9, 2018 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
Pharmacyclics LLC v. Hetero USA Inc., 18-1778 (D. Del.) Nov. 12, 2018 Hon. Colm F. Connolly Imbruvica® (ibrutinib capsules) 8,754,090
9,296,753
9,540,382
9,713,617
9,725,455
Boehringer Ingelheim Pharms. Inc. v. Dr. Reddy’s Labs., Ltd., 18-1779 (D. Del.) Nov. 12, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 9949998
7713938
Dr. Reddy’s Labs., Inc. v. AstraZeneca AB, 18-16057 (D.N.J.) Nov. 12, 2018 Hon. Renee Marie Bumb Nexium® 24HR (esomeprazole magnesium delayed-release oral tablets) 6,428,810
Boehringer Ingelheim Pharms. Inc. v. Aizant Drug Research Solutions PRV. Ltd., 18-1783 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. MSN Labs. Private Ltd., 18-1785 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
Synjardy® XR (empagliflozin / metformin extended-release tablets)
8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. Annora Pharma Private Ltd., 18-1786 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets)
Glyxambi® (empagliflozin / linagliptin tablets)
8,551,957
9,949,997
9,949,998
Boehringer Ingelheim Pharms. Inc. v. Prinston Pharm. Inc., 18-1787 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Glyxambi® (empagliflozin / linagliptin tablets) 8551957
9949998
Boehringer Ingelheim Pharms. Inc. v. Invagen Pharms., Inc., 18-1788 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Jardiance® (empagliflozin tablets) 9,949,998
Boehringer Ingelheim Pharms. Inc. v. Cipla Ltd., 18-1789 (D. Del.) Nov. 13, 2018 Hon. Colm F. Connolly Synjardy® XR (empagliflozin / metformin extended-release tablets) 9,949,998
Dr. Reddy’s Labs. S.A. v. Indivior UK Ltd., IPR2019-00328 (PTAB) Nov. 13, 2018 N/A Suboxone® (buprenorphine HCl / naloxone HCl film) 9,687,454
Dr. Reddy’s Labs. S.A. v. Indivior UK Ltd., IPR2019-00329 (PTAB) Nov. 13, 2018 N/A Suboxone® (buprenorphine HCl / naloxone HCl film) 9,687,454
Genzyme Corp. v. Apotex Inc., 18-1795 (D. Del.) Nov. 14, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 7,196,205
Genzyme Corp. v. Teva Pharms. USA, Inc., 18-1796 (D. Del.) Nov. 14, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 6,916,802
7,196,205
7,253,185
7,615,573
Medicure Int’l, Inc. v. Gland Pharma Ltd., 18-16246 (D.N.J.) Nov. 16, 2018 Hon. Kevin McNulty Aggrastat® (tirofiban HCl for injection) 6,770,660
Astellas Pharma Inc. v. Xellia Pharms. APS, 18-1818 (D. Del.) Nov. 19, 2018 Hon. Richard G. Andrews Mycamine® (micafungin sodium for injection) 6,774,104
Maia Pharms., Inc. v. Bracco Diagnostics Inc., IPR2019-00345 (PTAB) Nov. 19, 2018 N/A Kinevac® (sincalide for injection) 6,803,046
Genzyme Corp. v. Aizant Drug Research Solutions Private Ltd., 18-1837 (D. Del.) Nov. 20, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 7,196,205
Genzyme Corp. v. Cipla Ltd., 18-1838 (D. Del.) Nov. 20, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 6,916,802
7,196,205
7,253,185
7,615,573
Genzyme Corp. v. Dr. Reddy’s Labs., Inc., 18-1839 (D. Del.) Nov. 20, 2018 Hon. Colm F. Connolly Cerdelga® (eliglustat capsules) 7,196,205
Genzyme Corp. v. Dr. Reddy’s Labs., Inc., 18-16378 (D.N.J.) Nov. 21, 2018 Hon. Brian R. Martinotti Cerdelga® (eliglustat capsules) 7,196,205
Celgene Corp. v. Apotex Inc., 18-16395 (D.N.J.) Nov. 21, 2018 Hon. Esther Salas Pomalyst® (pomalidomide capsules) 9,993,467
AstraZeneca Pharms. LP v. Alkem Labs. Ltd., 18-16399 (D.N.J.) Nov. 21, 2018 Hon. Freda L. Wolfson Daliresp® (roflumilast tablets) 8,536,206
8,604,064
8,618,142
Leo Pharma A/S v. Perrigo UK Finco Ltd. Partnership, 18-1874 (D. Del.) Nov. 27, 2018 Hon. Colm F. Connolly Finacea® (azelaic acid foam) 10,117,812
BTG Int’l Ltd. v. Qilu Pharm. Co., Ltd., 18-16521 (D.N.J.) Nov. 28, 2018 Hon. Kevin McNulty Zytiga® (abiraterone acetate tablets) 8,822,438
Duchesnay Inc. v. Actavis Labs. FL, Inc., 18-1895 (D. Del.) Nov. 29, 2018 Hon. Richard G. Andrews Bonjesta® (doxylamine succinate / pyridoxine HCl extended-release tablets) 9,089,489
9,375,404
9,526,703
9,937,132
Collegium Pharm., Inc. v. Teva Pharms. USA, Inc., 18-1900 (D. Del.) Nov. 30, 2018 Hon. Leonard P. Stark Xtampza® ER (oxycodone extended-release capsules) 9968598
10004729
Duchesnay Inc. v. Actavis Labs. FL, Inc., 18-25015 (S.D. Fla.) Nov. 30, 2018 Hon. Kathleen M. Williams Bonjesta® (doxylamine succinate / pyridoxine HCl extended-release tablets) 9,089,489
9,375,404
9,526,703
9,937,132
Boehringer Ingelheim Pharms., Inc. v. Lupin Atlantis Holdings SA, 18-16708 (D.N.J.) Nov. 30, 2018 Hon. Brian R. Martinotti Spiriva® HandiHaler® (tiotropium bromide inhalation powder) 6,777,423
6,908,928
7,309,707
7,642,268
Bayer Intellectual Property GmbH v. Teva Pharms. USA, Inc., 18-1926 (D. Del.) Dec. 5, 2018 Hon. Richard G. Andrews Xarelto® (rivaroxaban tablets) 9,539,218
Genzyme Corp. v. Fresenius Kabi USA, LLC, 18-1934 (D. Del.) Dec. 6, 2018 Hon. Kent A. Jordan Mozobil® (plerixafor for injection) 7897590
6987102
Pfizer Inc. v. Teva Pharms. USA, Inc., 18-1940 (D. Del.) Dec. 7, 2018 Hon. Leonard P. Stark Xeljanz XR® (tofacitinib extended-release tablets) 9,937,181
Adapt Pharma Operations Ltd. v. Perrigo UK Finco Ltd. Partnership, 18-16987 (D.N.J.) Dec. 7, 2018 Hon. Jose L. Linares Narcan® (naloxone HCl nasal spray) 10,085,937
Senju Pharm. Co., Ltd. v. Amneal Pharms. LLC, 18-16991 (D.N.J.) Dec. 7, 2018 Hon. Brian R. Martinotti Prolensa® (bromfenac ophthalmic solution) 10,085,958
Eagle Pharms., Inc. v. Slayback Pharma LLC, 18-1953 (D. Del.) Dec. 11, 2018 Hon. Colm F. Connolly Balrapzo® (bendamustine HCl for injection) 9,265,831
9,572,796
9,572,797
10,010,533
Silvergate Pharms., Inc. v. Bionpharma Inc., 18-1962 (D. Del.) Dec. 12, 2018 Hon. Leonard P. Stark Epaned® (enalapril maleate solution) 9,669,008
9,808,442
10,039,745
Merz Pharms., LLC v. Suven Life Sciences, Ltd., 18-0584 (E.D.N.C.) Dec. 12, 2018 Hon. Terrence W. Boyle Cuvposa® (glycopyrrolate solution) 7638552
7816396
Keryx Biopharmaceuticals, Inc. v. Lupin Ltd., 18-1968 (D. Del.) Dec. 13, 2018 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 5,753,706
7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,757,416
9,387,191
AstraZeneca Pharms. LP v. Chia Tai Tianqing Pharm. Group Co., Ltd., 18-17194 (D.N.J.) Dec. 13, 2018 Hon. Renee Marie Bumb Faslodex® (fulvestrant for injection) 6,774,122
7,456,160
8,329,680
8,466,139
Apotex Inc. v. UCB Biopharma SPRL, IPR2019-00400 (PTAB) Dec. 13, 2018 N/A Xyzal® Allergy 24HR (levocetirizine dihydrochloride solution) 8,633,194
Valeant Pharms. North America LLC v. Amneal Pharms. LLC, 18-17246 (D.N.J.) Dec. 14, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Vifor Fresenius Medical Care Renal Pharma Ltd. v. Annora Pharma Private Ltd., 18-1996 (D. Del.) Dec. 17, 2018 Hon. Leonard P. Stark Velphoro® (sucroferric oxyhydroxide chewable tablets) 9,561,251
Abraxis Bioscience, LLC v. HBT Labs, Inc., 18-17304 (D.N.J.) Dec. 17, 2018 Hon. John Michael Vazquez Abraxane® (paclitaxel protein-bound particles for injection) 7,758,891
7,820,788
7,923,536
8,034,375
8,138,229
8,268,348
8,314,156
8,853,260
9,101,543
9,393,318
9,511,046
9,597,409
Valeant Pharms. Int’l v. Sun Pharm. Indus., Ltd., 18-17312 (D.N.J.) Dec. 17, 2018 Hon. Peter G. Sheridan Uceris® (budesonide tablets) 10,064,878
AstraZeneca AB v. Apotex Inc., 18-2010 (D. Del.) Dec. 18, 2018 Hon. Richard G. Andrews Movantik® (naloxegol tablets) 9,012,469
Keryx Biopharmaceuticals, Inc. v. Teva Pharms. USA, Inc., 18-2012 (D. Del.) Dec. 19, 2018 Hon. Leonard P. Stark Auryxia® (ferric citrate tablets) 7,767,851
8,093,423
8,299,298
8,338,642
8,609,896
8,754,257
8,754,258
8,846,976
8,901,349
9,050,316
9,328,133
9,387,191
9,757,416
Abraxis Bioscience, LLC v. HBT Labs, Inc., 18-2019 (D. Del.) Dec. 19, 2018 Hon. Richard G. Andrews Abraxane® (paclitaxel protein-bound particles for injection) 7,758,891
7,820,788
7,923,536
8,034,375
8,138,229
8,268,348
8,314,156
8,853,260
9,101,543
9,393,318
9,511,046
9,597,409
Par Pharm., Inc. v. Amphastar Pharms., Inc., 18-2032 (D. Del.) Dec. 20, 2018 Hon. Colm F. Connolly Vasostrict® (vasopressin injection) 9,375,478
9,687,526
9,744,209
9,744,239
9,750,785
9,937,223
Celgene Corp. v. Hetero Labs Ltd., 18-17463 (D.N.J.) Dec. 20, 2018 Hon. Susan D. Wigenton Revlimid® (lenalidomide capsules) 7,465,800
7,855,217
7,468,363
8,741,929
Valeant Pharms. North America LLC v. Lupin Ltd., 18-17501 (D.N.J.) Dec. 21, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Perrigo Pharma Int’l DAC, 18-17518 (D.N.J.) Dec. 21, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Eli Lilly and Co. v. Qilu Pharm. Co., Ltd., 18-17554 (D.N.J.) Dec. 24, 2018 Hon. William H. Walls Cialis® (tadalafil tablets) 6,943,166
AstraZeneca AB v. MSN Pharms., Inc., 18-2051 (D. Del.) Dec. 26, 2018 Hon. Richard G. Andrews Movantik® (naloxegol tablets) 9,012,469
Janssen Products, L.P. v. Amneal Pharms. LLC, 18-17585 (D.N.J.) Dec. 26, 2018 Hon. William H. Walls Prezista® (darunavir tablets) 8,518,987
7,126,015
7,595,408
Biogen Int’l GMBH v. Banner Life Sciences LLC, 18-2054 (D. Del.) Dec. 27, 2018 Hon. Leonard P. Stark Tecfidera® (dimethyl fumarate delayed-release capsules)
Bafiertam® (dimethyl fumarate delayed-release capsules)
7,619,001
Valeant Pharms. North America LLC v. Alkem Labs. Ltd., 18-17731 (D.N.J.) Dec. 28, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444
Valeant Pharms. North America LLC v. Aurobindo Pharma USA Inc., 18-17733 (D.N.J.) Dec. 28, 2018 Hon. Peter G. Sheridan Jublia® (efinaconazole topical solution) 10,105,444

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.